Glycine acts as an inhibitory neurotransmitter in the central nervous system, potentially modulating neuronal excitability and reducing neurogenic inflammation associated with cluster headaches. When administered, it may help decrease pain signaling and provide a neuroprotective effect by interacting with glycine receptors and NMDA receptor modulatory sites, thereby potentially alleviating the intense pain characteristic of cluster headache episodes.